当前位置:
X-MOL 学术
›
Lancet Respir. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Heterologous ChAdOx1-nCoV19-BNT162b2 vaccination provides superior immunogenicity against COVID-19.
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2021-08-13 , DOI: 10.1016/s2213-2600(21)00366-0 Christopher D Richardson 1
中文翻译:
异源 ChAdOx1-nCoV19-BNT162b2 疫苗接种可提供针对 COVID-19 的卓越免疫原性。
更新日期:2021-08-12
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2021-08-13 , DOI: 10.1016/s2213-2600(21)00366-0 Christopher D Richardson 1
Affiliation
中文翻译:
异源 ChAdOx1-nCoV19-BNT162b2 疫苗接种可提供针对 COVID-19 的卓越免疫原性。